Question 1

What are the potential side effects of ACU-4429?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy clinical trial (NCT01002950). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatments available for geographic atrophy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy clinical trial (NCT01002950). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my visits involve, and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy clinical trial (NCT01002950). Contact the study team or your healthcare provider for specific answers.

Question 4

How will I know if the treatment is working for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy clinical trial (NCT01002950). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy clinical trial (NCT01002950). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy clinical trial (NCT01002950). Contact the study team or your healthcare provider for specific answers.

What this study is about